Sunday review: GlaxoSmithKline, Elliott Management and Caxton Associates
Chums at the Mail on Sunday dug out a decent tale about top institutional shareholders backing GlaxoSmithKline in its running battle with American hedgie Elliott Management.
What caught Betaville's eye, though, was a line a few pars into the report about speculation that is "rife that activist Elliott is set to push for a dramatic new plan that could see the FTSE 100 firm sold off in parts or swallowed up by a foreign rival". Below is a link to Alex Lawson's scoop:..
Register for free to see rest of this article and all public articles from BetavilleLogin / Register